Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 104 results for "Tecfidera Treated Patients"

Biogen Idec's Tecfidera Captures the Largest U.S. Neurologist-Reported Patient Share Among Oral Disease-Modifying Multiple Sclerosis Therapies Ten Months Post-Launch
Review Seeker

Biogen Idec's Tecfidera Captures the Largest U.S. Neurologist-...

/PRNewswire/ --Decision Resources Group finds that Biogen Idec's Tecfidera, the third-to-market oral disease-modifying therapy (DMT), has become the patient share leader among the oral options available for the treatment of relapsing forms of ... ADVFN India, 4 weeks ago
[x]  

1 images for "Tecfidera Treated Patients"

Review Seeker, 4 weeks ago

Health Canada Approves New Strength For TECFIDERA(TM), A First-Line Oral Treatment For Multiple Sclerosis

TECFIDERA now available as 240 mg delayed-release capsules MISSISSAUGA, ON, Feb. 18, 2014 /CNW/ - Today, Biogen Idec Canada announces the Health Canada approval of TECFIDERA (dimethyl fumarate) 240 mg strength capsule, a first-line oral treatment ...
 Canada NewsWire1 month ago

NICE issue initial negative review on new MS treatment, Tecfidera

NICE have said theyre minded to say no to allowing the new oral MS drug dimethyl fumarate (Tecfidera) to be freely available on the NHS in England and Wales for people with relapsing remitting MS . The drug was licensed earlier this month to ...
 Multiple Sclerosis Society1 month ago Dimethyl fumarate (BG-12, Tecfidera) - NICE gives initial "no" decision  Multiple Sclerosis Trust1 month ago NICE says initial 'no' to MS drug  BootsWebMD1 month ago
Jutia Group

Biogen to Present Clinical Data from Neurology Portfolio at AAN Annual Meeting

- Two-Year Data from Pivotal Phase 3 ADVANCE Study for PLEGRIDY (Peginterferon Beta-1a) to Be Presented - - New TECFIDERA® (dimethyl fumarate) Data Underscore Efficacy, Consistent with Growing Global Experience with Greater than 65,000 Patients ...
 Benzinga.com3 days ago Biogen Idec to Present New Clinical Data from Its Robust Neurology Portfolio at AAN Annual Meeting  BusinessWeek3 days ago Company Update: Biogen Idec Inc (NASDAQ:BIIB) U.S. FDA approves Biogen's hemophilia B drug Alprolix  Jutia Group2 weeks ago BIOGEN IDEC : to Report Clinical Data from Its Neurology Portfolio at AAN Annual Meeting  4 Traders1 day ago
[x]  

Biogen Idec May Have Seeds For Next-Gen MS Drugs

Biogen Idec ( BIIB ), on the IBD 50 list of top-rated growth stocks, is working on a new oral drug for treating multiple sclerosis that has the potential for driving the biotech firm's next generation of MS therapies, according to a research note ...
 Investor's Business Daily1 week ago
Motley Fool

A New Frontier for Biogen Idec, Inc.?

Times are changing for Biogen Idec ( NASDAQ: BIIB ) . The longtime leader in the development of drugs for treating multiple sclerosis just expanded its territory. Last Friday, the Food and Drug Administration granted approval for Biogen's ...
 Motley Fool2 weeks ago

Opexa Therapeutics: A Long-Term Perspective For Price Appreciation

Summary Tcelna has the opportunity to provide patients with a first in line therapy for Secondary Progressive Multiple Sclerosis that is not toxic. Opexa investors that remain long term have the ability to reap huge rewards if the phase 2b trial ...
 Seeking Alpha1 month ago

Human medicines European public assessment report (EPAR): Tecfidera, dimethyl fumarate, Revision: 0, Authorised

This is a summary of the European public assessment report (EPAR) for Tecfidera. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on ...
 European Medicines Agency1 month ago
Daily Record

Tecfidera is approved by Scottish Medicines Consortium for Scots with relapsing-remitting multiple sclerosis

TECFIDERA is said to significantly reduce the number of MS relapses and slow the progression of the disease. A NEW oral drug for people with relapsing-remitting multiple sclerosis is to be made available in Scotland. Tecfidera (dimethyl ...
 Daily Record1 week ago
EMax Health

Statins May Benefit Secondary Progressive MS Patients

The cholesterol-lowering drugs known as statins are controversial for a number of reasons, but for people who are suffering with secondary progressive multiple sclerosis (MS), they may prove to be beneficial. A British team of researchers from ...
 EMax Health3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less